Moving goalposts--regulatory oversight of antibacterial drugs.
expert_opinion · Level V
Where this comes from
- Record sourced from PubMed, PMID 17160053.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Is uncertainty concerning the regulation of antimicrobial drug trials stifling investment in infectious disease treatments? Here, experts from a large pharma company and a biotech firm provide their perspectives.
Medical subject headings
- Anti-Bacterial Agents
- Biotechnology
- Clinical Trials as Topic
- Drug Approval
- Drug Industry